Total Payments
$16,317
2024 Payments
$1,504
Companies
55
Transactions
875
Medicare Patients
22,746
Medicare Billing
$2.3M
Payment Breakdown by Category
Food & Beverage$14,921 (91.4%)
Travel$806.98 (4.9%)
Consulting$413.92 (2.5%)
Other$115.57 (0.7%)
Education$59.40 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,921 | 867 | 91.4% |
| Travel and Lodging | $806.98 | 2 | 4.9% |
| Consulting Fee | $413.92 | 1 | 2.5% |
| Entertainment | $115.57 | 1 | 0.7% |
| Education | $59.40 | 4 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,405 | 98 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $1,226 | 64 | $0 (2024) |
| PFIZER INC. | $1,157 | 80 | $0 (2024) |
| HeartFlow, Inc. | $1,050 | 6 | $0 (2023) |
| Abbott Laboratories | $1,004 | 32 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $908.51 | 78 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $880.94 | 62 | $0 (2024) |
| BIOTRONIK INC. | $861.61 | 36 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $830.77 | 58 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $810.55 | 64 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,504 | 69 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($208.25) |
| 2023 | $2,744 | 85 | HeartFlow, Inc. ($1,021) |
| 2022 | $1,608 | 92 | Janssen Pharmaceuticals, Inc ($202.89) |
| 2021 | $1,378 | 76 | BOSTON SCIENTIFIC CORPORATION ($228.81) |
| 2020 | $1,528 | 87 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($250.17) |
| 2019 | $2,658 | 172 | Amgen Inc. ($437.57) |
| 2018 | $2,819 | 145 | Change Healthcare Technologies, LLC ($520.00) |
| 2017 | $2,078 | 149 | PFIZER INC. ($358.47) |
All Payment Transactions
875 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.26 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/04/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $25.68 | General |
| Category: Medical Device | ||||||
| 12/03/2024 | Medtronic, Inc. | TYRX (Device) | Food and Beverage | In-kind items and services | $28.51 | General |
| Category: Antibacterial Mesh | ||||||
| 11/20/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $23.75 | General |
| 11/14/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/13/2024 | BIOTRONIK INC. | BIOMONITOR (Device) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $28.25 | General |
| Category: Obesity | ||||||
| 11/05/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Not Applicable | ||||||
| 10/30/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Cardiology | ||||||
| 10/29/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Not Applicable | ||||||
| 10/16/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/10/2024 | Regeneron Healthcare Solutions, Inc. | PRALUENT (Biological), EVKEEZA | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 10/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: Obesity | ||||||
| 10/01/2024 | BIOTRONIK INC. | AMVIA EDGE (Device), Acticor 7 VR-T DX | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/27/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Not Applicable | ||||||
| 09/25/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $19.37 | General |
| 09/23/2024 | BIOTRONIK INC. | Acticor 7 VR-T DX (Device) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/19/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $27.72 | General |
| Category: Cardiology | ||||||
| 08/26/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Cardiology | ||||||
| 08/22/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $139.27 | General |
| Category: Heart Failure | ||||||
| 08/13/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/06/2024 | BIOTRONIK INC. | Acticor 7 VR-T DX (Device) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/02/2024 | BIOTRONIK INC. | Acticor 7 VR-T DX (Device) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/31/2024 | Medtronic, Inc. | TYRX (Device) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: Antibacterial Mesh | ||||||
| 07/31/2024 | Medtronic, Inc. | TYRX (Device) | Education | In-kind items and services | $13.26 | General |
| Category: Antibacterial Mesh | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 44 | 5,724 | 9,154 | $2.2M | $554,070 |
| 2022 | 41 | 6,134 | 10,957 | $1.8M | $627,325 |
| 2021 | 43 | 5,767 | 9,940 | $1.6M | $605,081 |
| 2020 | 39 | 5,121 | 12,157 | $1.2M | $509,545 |
Total Patients
22,746
Total Services
42,208
Medicare Billing
$2.3M
Procedure Codes
176
All Medicare Procedures & Services
176 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 1,126 | 1,543 | $352,673 | $136,454 | 38.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 188 | 189 | $187,620 | $58,353 | 31.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 305 | 308 | $105,888 | $40,083 | 37.9% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 191 | 383 | $70,987 | $33,617 | 47.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 244 | 495 | $73,476 | $30,220 | 41.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 519 | 532 | $262,694 | $28,138 | 10.7% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 272 | 489 | $86,248 | $27,509 | 31.9% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 309 | 985 | $102,342 | $20,652 | 20.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 241 | 263 | $40,428 | $14,954 | 37.0% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 309 | 985 | $87,104 | $14,814 | 17.0% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 38 | 38 | $70,081 | $14,530 | 20.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 136 | 137 | $38,244 | $13,683 | 35.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 119 | 119 | $41,652 | $13,277 | 31.9% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 44 | 319 | $110,441 | $12,342 | 11.2% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 59 | 59 | $119,852 | $11,745 | 9.8% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 67 | 268 | $31,816 | $11,559 | 36.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 59 | 61 | $24,581 | $8,169 | 33.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 50 | 57 | $19,058 | $7,526 | 39.5% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 143 | 143 | $49,797 | $6,476 | 13.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 45 | 59 | $12,457 | $5,420 | 43.5% |
| 93279 | Programming of single lead pacemaker system | Office | 2023 | 65 | 113 | $17,194 | $5,354 | 31.1% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 39 | 290 | $22,420 | $5,100 | 22.7% |
| 33228 | Removal and replacement of dual lead permanent pacemaker | Facility | 2023 | 20 | 20 | $18,589 | $4,972 | 26.7% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 19 | 19 | $45,368 | $4,898 | 10.8% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 43 | 46 | $25,927 | $3,621 | 14.0% |
About Dr. Jeffrey Rieder, MD
Dr. Jeffrey Rieder, MD is a Interventional Cardiology healthcare provider based in Charleston, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255397519.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Rieder, MD has received a total of $16,317 in payments from pharmaceutical and medical device companies, with $1,504 received in 2024. These payments were reported across 875 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($14,921).
As a Medicare-enrolled provider, Rieder has provided services to 22,746 Medicare beneficiaries, totaling 42,208 services with total Medicare billing of $2.3M. Data is available for 4 years (2020–2023), covering 176 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Location Charleston, SC
- Active Since 04/25/2006
- Last Updated 05/24/2023
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1255397519
Products in Payments
- LifeVest (Device) $1,226
- ELIQUIS (Drug) $1,111
- FFRct (Device) $1,021
- XARELTO (Drug) $908.51
- Repatha (Biological) $836.61
- BRILINTA (Drug) $709.98
- ENTRESTO (Drug) $589.05
- Corlanor (Drug) $545.11
- CHANTIX (Drug) $532.91
- Horizon Cardiology (Device) $520.00
- WATCHMAN (Device) $497.98
- JARDIANCE (Drug) $461.97
- AMPLATZER AMULET (Device) $235.58
- LEQVIO (Drug) $221.50
- MULTAQ (Drug) $213.67
- Arcalyst (Drug) $212.49
- CAMZYOS (Drug) $194.03
- PRADAXA (Drug) $186.67
- ONPATTRO (Drug) $173.32
- UPTRAVI (Drug) $170.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Charleston
Daniel Steinberg, M.d, M.D
Interventional Cardiology — Payments: $699,293
Interventional Cardiology $699,293
Matthew O'steen, M.d., F.a.c.c, M.D., F.A.C.C
Interventional Cardiology — Payments: $88,664
Interventional Cardiology $88,664
Mr. William Yarbrough, M.d, M.D
Interventional Cardiology — Payments: $69,940
Interventional Cardiology $69,940
Richard Han, M.d, M.D
Interventional Cardiology — Payments: $35,199
Interventional Cardiology $35,199
Dr. Scott Woodfield, M.d., Facc, M.D., FACC
Interventional Cardiology — Payments: $27,431
Interventional Cardiology $27,431
Dr. William Ellison, M.d, M.D
Interventional Cardiology — Payments: $6,665
Interventional Cardiology $6,665